Veriskin, founded in 2016 by Carl Edman and Eugene Tu, is a San Diego-based software company focused on revolutionizing skin cancer screening. Their core mission is to provide non-invasive, fast, reliable, and accurate diagnostic tools for front-line care providers. Veriskin's flagship product, TruScore, is a handheld device designed to offer objective and precise assessments of suspicious skin lesions, making early detection more accessible and efficient.
Notable affiliated individuals include co-founders Carl Edman and Eugene Tu. Veriskin has garnered attention for its innovative approach to skin cancer diagnostics, contributing significantly to the field with its user-friendly technology. The company has made a substantial impact by improving early detection rates and streamlining the diagnostic process, thereby enhancing patient outcomes and supporting healthcare providers in delivering better care.
